# Better MedTech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/better-medtech

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.bettermedtech.com
- Latest round: Angel (Nov 1, 2021)
- Investors on record: 1

## About

Established in 2021 and based in Shanghai, China, Better MedTech operates as a medical device manufacturer dedicated to providing urology and pelvic floor health products. Its total area is about 3,300 square meters, including a manufacturing centre, a R&D centre, a testing centre, and an operation centre. The founder and CEO of the company, Yichen Zhu graduated from Fudan University. The co-founder and CTO of the company, Mingchen He graduated from Shandong University. In January 2024, Better MedTech raised approximately CNY 100 million in pre-series A+ funding co-led by new investors Sunland Capital and Vision Plus Capital.

The company mainly provides three product lines, which are benign prostatic hyperplasia (BPH), urinary stones, and endoscopy. The BPH product line include prostate stents, ureteral stents, and other benign prostatic hyperplasia treatment-related products. The urological stone product line provides urological medical devices such as stone blocking and lithotomy baskets. The endoscopy product line includes disposable flexible ureteroscope, disposable cystoscope, and other endoscope related products. The products are targeted at benign prostatic hyperplasia, urinary incontinence, stones and innovative cancer treatments.

The company will innovate its urinary and pelvic floor health product lines, expand its pipeline and conduct clinical research.

## Funding rounds

- Angel, Nov 1, 2021 — China Growth Capital

## Investors

- China Growth Capital (https://capitalatlas.ai/funds/china-growth-capital) — Angel